Researchers examined the original framework of the NHS Diabetes Prevention Programme (DPP) implemented in the UK.
Bristol Myers nabs approval for Opdivo combo as first-line bladder cancer treatment
Bristol Myers Squibb won another approval for its blockbuster cancer drug Opdivo, this time to treat a type of bladder cancer in combination with chemotherapies,